Cellebrite DI Ltd. CLBT
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Net Income | -- | 78.33M | 76.33M | -150.95M | |
| Total Depreciation and Amortization | -- | 11.87M | 10.66M | 10.57M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | 36.75M | 26.20M | 247.60M | |
| Change in Net Operating Assets | -- | 46.61M | 39.52M | 53.85M | |
| Cash from Operations | -- | 173.54M | 152.70M | 161.08M | |
| Capital Expenditure | -- | -13.23M | -12.45M | -10.95M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -147.46M | 0.00 | -2.75M | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -107.57M | -25.64M | -106.85M | |
| Cash from Investing | -- | -268.25M | -38.09M | -120.54M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | 25.05M | 29.44M | 29.72M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | 0.00 | -11.00K | |
| Cash from Financing | -- | 25.05M | 29.44M | 29.70M | |
| Foreign Exchange rate Adjustments | -- | 2.45M | 957.00K | 2.03M | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -67.20M | 145.01M | 72.27M | |